Empliciti™ (elotuzumab) - Multiple Myeloma Research Foundation

MULTIPLE MYELOMA KNOWLEDGE CENTER

What is Empliciti?

Empliciti™, also known as elotuzumab, is a monoclonal antibody approved for use in multiple myeloma. Empliciti is made by Bristol-Myers Squibb and AbbVie.

The Multiple Myeloma Research Consortium (MMRC) has played a role in this drug’s development and is currently facilitating several trials evaluating Empliciti in combination with other myeloma agents.

Read the Press Release

uses2 side effects2 dosing2 clinical studies2